Clinical Trial for Valuation of the Effectiveness of Lactoferrine in the Prevention of Sepsis in New Premature Born. Bimonitorization of the Antinflammatory Mechanisms, Antioxidants and the Intestinal Microbiote.

NCT03472170 · clinicaltrials.gov ↗

NA

Phase

UNKNOWN

Status

120

Enrollment

OTHER

Sponsor class

Conditions

SEPSIS SYNDROME

Interventions

DIETARY_SUPPLEMENT: Enteral administration of bovine lactoferrin (bLf)
OTHER: Enteral administration of placebo

Sponsor

Maimónides Biomedical Research Institute of Córdoba